Genmab A (GMAB) Raw Materials (2023 - 2025)

Genmab A (GMAB) has disclosed Raw Materials for 3 consecutive years, with $6.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials rose 500.0% year-over-year to $6.0 million, compared with a TTM value of $6.0 million through Dec 2025, up 500.0%, and an annual FY2025 reading of $6.0 million, up 500.0% over the prior year.
  • Raw Materials was $6.0 million for Q4 2025 at Genmab A, up from $1.0 million in the prior quarter.
  • Across five years, Raw Materials topped out at $6.0 million in Q4 2025 and bottomed at $1.0 million in Q4 2024.
  • Average Raw Materials over 3 years is $3.0 million, with a median of $2.0 million recorded in 2023.
  • The sharpest move saw Raw Materials tumbled 50.0% in 2024, then skyrocketed 500.0% in 2025.
  • Year by year, Raw Materials stood at $2.0 million in 2023, then crashed by 50.0% to $1.0 million in 2024, then surged by 500.0% to $6.0 million in 2025.
  • Business Quant data shows Raw Materials for GMAB at $6.0 million in Q4 2025, $1.0 million in Q4 2024, and $2.0 million in Q4 2023.